VIGL Vigil Neuro Company Cash Volume

Graphic logo of vigilneuro.com (VIGL)

Vigil Neuroscience attracts leading neuroimmunologists with its cutting-edge research on brain microglia. The company's financial viability is based on the success of clinical programs for treating rare pathologies. The business relies on unique developments, making it a defensive asset independent of macroeconomic factors. The company's cash balance demonstrates liquidity, where the value of 0.07 characterizes this level.

VIGL - Vigil Neuroscience Company Liquid Assets over the range 07/04/2022 - 08/16/2025

Vigil Neuroscience (VIGL) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Fundamental company analysis:Vigil Neuroscience, Inc.
Signature product of Vigil Neuro

Capital volume distinguishes stable enterprises from speculative assets. The stability of Vigil Neuroscience (VIGL) is confirmed by the exclusivity of its molecules and FDA support, which prevents patient attrition. This cash balance chart illustrates the liquid reserves necessary to cover operating expenses during revenue declines. This price action reflects the burn rate of the cash cushion during periods of market volatility. A high cash balance guarantees the financial viability of Vigil Neuroscience (VIGL).

Competitors of Vigil Neuroscience (VIGL)

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Volume AMLX (amylyx.com)|Company Liquid Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Company Cash Volume|Company Cash Reserve Anavex|CBLL (CeriBell Inc) - Company Cash on Hand|Company Cash and Cash Equivalents PRTA|Company Cash Funds Alector Inc.|Company Cash Reserve Annexon, Inc. ANNX|Company Cash Funds Omeros Corp (OMER)|NGNE (Neurogene Inc) - Company Cash Balance|Company Cash Funds AC Immune Inc ACIU|Company Cash Position Voyager Corp|Neumora Corp - Company Cash Volume|scilexholding.com (SCLX) - Company Cash on Hand|Tevogen Bio Holdings, Inc. (TVGN) - Company Cash Funds|Alpha Cognition Corp (ACOG) - Company Cash Volume|Company Cash on Hand CGTX|Company Cash and Cash Equivalents IKT (Inhibikase)|Company Cash Volume SAVA|Assertio - Company Cash and Cash Equivalents|Company Cash Volume COYA (Coya Therapeutics)|Company Cash Volume Vistagen Therapeutics VTGN|OVID: Company Cash on Hand|ABOS - Company Cash Volume|CRVO: Company Cash Volume|Company Cash Reserve Alterity Therapeutics Ltd. (ATHE)|Company Cash Funds Clene Inc.|pepgen.com (PEPG) - Company Liquid Assets|Company Cash on Hand JUNS (jupiterneurosciences.com)|Company Cash Funds RLMD (Relmada Corp)|Annovis Bio, Inc. - Company Cash on Hand|Company Cash Position Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Company Cash Volume|KLTO - Company Cash Volume|NRSN (NeuroSense Therapeutics Ltd.) - Company Cash on Hand|RVPH - Company Liquid Assets|Company Cash Funds MetaVia|Company Cash and Cash Equivalents NRXS (neuraxis.com)|Company Cash Funds Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Company Cash Balance|Company Cash Volume NEUP (Neuphoria Therapeutics)|Company Cash Balance NERV|ATHA - Company Cash Funds|Company Total Cash Volume ADXN|ALZN (Alzamend Neuro) - Company Cash on Hand|Company Cash and Cash Equivalents CYCN|PTIX (Protagenic Therapeutics, Inc.) - Company Cash Volume|KTTA: Company Cash Balance|Company Cash Funds Cortigent Medical (CRGT)|ATXI - Company Cash Reserve|Company Cash Volume BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Cash Reserve|CHRO: Company Cash on Hand|Eliem Therapeutics Inc. (ELYM) - Company Cash on Hand|Intra-Cellular Therapies Inc. (ITCI) - Company Cash Funds|Company Total Cash Volume LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Company Cash Volume|Company Cash and Cash Equivalents NKGN (NKGen Biotech Inc)|Company Cash Volume NRBO|Company Cash on Hand Sage Therapeutics Inc SAGE|Company Cash Funds Synaptogenix SNPX|TRVN: Company Cash and Cash Equivalents|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE